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Abstract
We describe two sibs with chorioretinal 
dystrophy, hypogonadotrophic hypogo­
nadism, and cerebellar ataxia, Boucher- 
Neuhäuser syndrome, a rare but distinct 
pleiotropic single gene disorder with an 
autosomal recessive pattern of inherit­
ance. The cases presented illustrate that 
this syndrome is still poorly recognised. 
We provide a review and analysis o f previ­
ously reported cases and the differential 
diagnosis, which might aid in the identifi­
cation of additional cases.
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In 1969, Boucher and Gibberd1 described two 
sisters with “a combination of several features 
which although frequently occurring alone or 
in pairs, rarely occur all in one patient” . T he 
features referred to are chorioretinal degenera­
tion, hypogonadism, and ataxia, which at that 
time did not “conform to any of the recognised 
syndromes”.
Six years later, Neuhäuser and Opitz2 
described a new autosomal recessive syndrome 
combining hypogonadotrophic hypogonadism 
and cerebellar ataxia. Although ophth almo logi­
cal examination of two patients described in 
this study showed retinal pigmentary changes 
and atrophy, these findings were no t consid­
ered to be part of the syndrome. T he similari­
ties between the cases reported by them and 
those reported by Boucher and Gibberd1 were 
therefore not recognised until 1989 when Lim ­
ber et a/,3 on re-evaluation of one of the patients 
described by Neuhäuser and Opitz,2 suggested 
that this was a specific pleiotropic single gene 
disorder and named it Boucher-Neuhäuser 
syndrome.
So far, 17 cases from nine families have been 
reported, only three of these families in genetic 
publications.1'10 In the present study, we 
describe two additional cases and after review­
ing the published reports list the m ain clinical 
characteristics of this rare syndrome and its 
differential diagnosis.
Case reports
CASH 1
The proband, a 31 year old male, was born  
after a normal pregnancy and delivery. He was 
seen by an ophthalmologist at the age of 23
years because of slowly progressive visual 
problems consisting of night blindness and 
constricting visual fields. His visual acuity was 
5/10 in both eyes. Intraocular pressure was 17 
m m H g on the right and 18 m m H g on the left. 
Fundos copy showed bilateral atrophy of the 
retinal pigment epithelium and choriocapillaris 
in the m id peripheral areas, with peripapillary 
atrophy and retinal pigment epithelium altera­
tions of the maculae. T he electro-oculogram 
was disturbed bilaterally while electroretinog- 
raphy showed no photopic or scotopic re­
sponses at all, A fluorescein angiogram indi­
cated central choriocapillaris atrophy. Colour 
discrimination was not disturbed. The diagno­
sis of choroideremia was suggested.
At 25 years of age, he was examined because 
of poor sexual development. H e never needed 
to shave and although he had erections on 
awakening no ejaculation occurred. His height 
was 178 cm (25th centile) and weight 65 kg 
(25th centile)» Compared to his trunks he had 
relatively long limbs. There was sparse pubic 
and normal axillary hair with absent chest and 
facial hair. There was no gynaecomastia and he 
had a normal masculine voice. He had a very 
small scrotum and his penis and testicles were 
small bu t without anatomical abnormalities. 
Laboratory tests3 including a complete blood 
count, routine blood chemistry profile, and 
urine analysis, were within normal limits. 
Endocrinological studies disclosed hypogona­
dotrophic hypogonadism. T he serum level of 
testosterone was extremely low (0.86 nmol/1, 
normal 10-35) and the concentrations of 
luteinising hormone (LH) and follicle stimulat­
ing horm one (FSH) were below the lowest 
detectable level (< 1.0 mIU/ml). There was no 
response to a single intravenous dose of L H  
releasing horm one (LH-RH) even after re­
peated stimulation with L H -R H  for one week, 
suggesting an abnormal pituitary function. The 
serum levels of oestradiol, cortisol, prolactin, 
thyroid stimulating horm one (TSH), and 
thyroxine (T4) were, however, all normal. Bone 
age, determined according to Greulich and 
Pyle, was 15 years 6 months. H e was treated 
with intramuscular horm one injections (250 
m g testosterone enantate (Testoviron©) every 
four weeks)* Subsequently, secondary sex 
characteristics appeared. T here was marked 
increase in facial and pubic hair growth and 
ejaculation occurred. Since the site of the hor­
m one injections was troubling the patient3 the 
injections were replaced by oral therapy (testo-
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sterone undecanoate (Andriol©), 80 mg/day)
after five years.
At the age of 30 years, an ophthalmological 
re-evaluation was performed at our clinic. At 
that time, his best corrected visual acuity was 
right 1/10 and left 5/10. T he cornea, anterior 
segment, lens, and vitreous were normal. Ocu­
lar motility and pupillary responses were not 
disturbed. His eyelashes were relatively long. 
Fundoscopy showed choroidal atrophy in the 
peripapillary region, small retinal vessels, pink 
coloured optic discs, and bone spicule-like 
clumps of pigment deposition, together with 
atrophy of the retinal pigment epithelium and 
choriocapillaris in the mid peripheral areas. 
Intraocular pressure was normal in both eyes. 
On electroretinography some photopic rest 
activity was seen while the electro-oculogram 
was flat. Colour vision examination showed a 
combined blue-yellow and red-green defect 
with anomaloscopic diminished red sensitivity. 
Goldmann perimetry showed a large temporal 
scotoma and a decrease of central sensitivity 
bilaterally. The diagnosis of atypical chorioreti­
nal dystrophy was made. The diagnosis of 
choroideremia was rejected because of the fun­
doscopy results and because his mother did not 
have fundoscopic signs of a choroideremia car­
rier.
CASE 2
The proband’s younger sister was born  after a 
normal pregnancy and delivery. She was first 
seen for prim ary amenorrhoea and poor sexual 
development at 21 years of age. On examin­
ation she was 175 cm (80th centile) in height 
and 58 kg (50th centile) in weight. Breast 
development was poor (Tanner 1-2) and only 
sparse pubic hair was present. Gynaecological 
examination showed hypoplastic external 
sexual organs. T he vagina and cervix were very 
small and the uterus and adnexal structures 
were clinically undetectable. A complete blood 
count and routine blood chemistry profile 
showed no abnormalities. Endocrinological 
studies, however, showed hypogonadotrophic 
hypogonadism. The serum level of oestradiol 
was 0.05 nmol/1 (normal 0.11-0.30) and the 
concentrations of LH  and FSH  were 1.2 and 
2.9 mlU/mlj respectively (normal LH 3-120, 
FSH  5-16). There was no response to a single 
intravenous dose of LH  releasing hormone. 
Serum concentrations of prolactin, cortisol, 
testosterone, TSH , triiodothyronine (T3), and 
T 4  were all within normal limits. Pelvic 
ultrasound showed a very narrow and small 
uterus. I t measured 0.5 cm in diameter and 
approximately 4.5 cm long. The adnexal struc­
tures could not be visualised properly. A diag­
nostic laparoscopy was performed and showed 
normal tubes and ovaries and a normal but 
small uterus. Radiographic evaluation of the 
sella turcica was unremarkable. The karyotype 
was 46,XX. Investigation of mitochondrial 
D NA did not show any deletions and the point 
mutations known for mitochondrial encepha- 
lomyopathy (MELAS) at position 3243 and 
3 2 5 2 a n d th e  point mutation known for neuro­
genic muscular weakness with ataxia and
retinitis pigmentosa (NARP) at position 8993 
were also excluded.
The patient was treated with an oral contra­
ceptive (Trisequens©) and within three years 
of therapy breast development and pubic hair 
growth both reached Tanner stage 5. The 
internal sexual organs however remained small 
and on temporary discontinuation of 
medication no menstrual periods occurred.
At the age of 24 years an ophthalmological 
evaluation was performed because she had 
noted that in the past three years her visual 
fields had narrowed progressively. Her best 
corrected visual acuity was right 5/10 and left 
5/10. Slit lamp examination of the anterior seg­
ments showed no abnormalities. Like her 
brother^ she had relatively long eyelashes. Fun­
doscopy showed atrophic retinal pigment 
epithelium alterations, narrow retinal vessels, 
and bone spicule-like clumps of pigment depo­
sition, very similar to the fundoscopic findings 
of her brother. On electoretinography some 
photopic rest activity was seen and the electro­
oculogram was flat. Colour vision examination 
showed a blue-yellow defect with anomalo­
scopic diminished red sensitivity. Visual field 
testing on a Goldmann perimeter showed a 
large ring scotoma and loss of central sensitiv­
ity bilaterally. The diagnosis was atypical 
chorioretinal dystrophy.
Since both brother and sister suffered from 
hypogonadotrophic hypogonadism and retinal 
degeneration, an inherited syndrome combin­
ing these two conditions had to be considered. 
Boucher-Neuhäuser syndrome was a likely 
candidate. Therefore, an extensive 
neurological evaluation of both patients was 
performed. Both the proband and his sister 
reported a slight disturbance of balance, first 
occurring during childhood. On examination a 
disturb ed balance and gait was evidently 
present in both patients. Furthermore, marked 
dysdiadochokinesis of the hands and an ataxic 
heel to shin test was found. Neither patient was 
able to walk on their heels, suggesting some 
degree of muscle weakness. The deep tendon 
reflexes were just elicitable or absent and there 
was moderate pes cavus in both patients. A 
gaze evoked horizontal and vertical nystagmus 
was found in case 2 . A reduction of propriocep­
tive sensation, fingertip number writing per­
ception, and dys stereo gnosis was found in the 
proband. Sensory examination was otherwise 
completely normal in both patients. Electro­
myogram showed broad complex motor unit 
potentials and decreased amplitudes. Nerve 
conduction velocities were not disturbed. MRI 
of the brain showed evident atrophy of the cer­
ebellum, most pronounced at the vermis
(fig I)-
The presence of spinocerebellar ataxia in 
addition to hypogonadotrophic hypogonadism 
and retinal degeneration confirmed the diagno­
sis of Boucher-Neuhäuser syndrome.
FAMILY HISTORY
The proband and his sister were born to 
healthy, non-consanguineous parents. In addi­
tion to these affected sibs, their parents had
Boucher-Neuhäuser syndrome 769
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Figure 1 T l weighted M R I  scan of the brain of the proband (A) and his sister (B ). 
Cerebellar atrophy can be seen, most, pronounced at the vermis (arrows). There is no 
atrophy of the base o f the pons.
three sons, all in good health. The family 
history was otherwise unremarkable.
Discussion
The occurrence of retinal degeneration, hy­
pogonadism, and cerebellar ataxia has been 
described in several syndromes with overlap­
ping clinical features (for example, Laurence- 
M oon syndrome, Bardet-Biedi syndrome, Al- 
ström syndrome, Usher syndrome). However, 
these syndromes can be distinguished from 
Boucher-Neuhäuser syndrome since they are 
complicated by additional features like deaf­
ness, glucose intolerance, mental retardation, 
polydactyly, spastic paraplegia, and various 
dysmorphic features.11 12 Disorders more simi­
lar to Boucher-Neuhäuser syndrome are infan­
tile onset spinocerebellar ataxia (IOSCA),n 
Oliver-McFarlane syndrome, 14 and Holmes 
type ataxia1^ (table 1). Because of the overlap­
ping features of Oliver-McFarlane syndrome, 
Holmes type ataxia, and Boucher-Neuhäuser 
syndrome one might even consider the 
possibility that they are clinical variants of a 
single disorder, particularly considering the 
fact that cerebellar hypoplasia was seen once in 
two sibs with Oliver-McFarlane syndrome.16
The association of all three disorders (chorio­
retinal degeneration, hypogonadotrophic hy­
pogonadism, and cerebellar ataxia) in one 
patient and without additional abnormalities 
remains rare, however. In retrospect, one of the 
first papers on this subject was written in 1962 
by Bernard-Weil and Endtz4 and before that 
Kapuscinski17 and De Mello1* also reported
cases with this triad. However, in these 
patients, m ental retardation and choreo- 
athethosis occurred and the type of hypogo­
nadism was unknown. Lowenthal et al19 re­
ported  similar cases, but these patients also 
suffered from oligophrenia, anosmia, and 
anomalies of amino acid distribution .19 Con­
sidering the complicating features, the patients 
described in the latter three articles can 
probably not be identified as Boucher- 
N euhäuser syndrome, in contrast to a previous 
repo rt .7 After further reviewing the published 
reports, at least 17 previously reported cases 
suffering from Boucher-Neuhäuser syndrome 
could be identified .1”10 Below, we list the most 
im portant clinical features (table 2) and 
discuss the variable presentation of this rare 
syndrome.
Besides the visual problems listed in table 2, 
several other symptoms like astigmatism ,2 night 
blindness,3 photophobia, 10 and disturbed depth 
perception3 have been described. T he onset of 
these visual problems varied from the ages of 4 
to 46 years.1 * The main fundoscopic findings 
have been extensively described previously by 
Salvador et a V Q As stated before,7 the absence 
of bone spicule type pigmentation, macular 
oedema, and abnormal retinal vessels should 
differentiate it from typical retinitis pigmen­
tosa. However, the diagnosis of retinitis pig­
mentosa was suggested in a few cases.3 6 
Besides retinitis pigmentosa other diagnoses 
like (early) senile macular degeneration,2 4 reti­
nal chorioretinitis,2 and choroideremia 
(present study) have been suggested. In 
addition, it seems that independent of the 
severity of the observed chorioretinal degen­
eration, the visual outcome varies between 
almost no loss of vision and complete blind­
ness. This illustrates the variable presentation 
of the ophthalmological manifestations in 
Boucher-Neuhäuser syndrome.
In  addition to the more common 
neurological findings in Boucher-Neuhäuser 
syndrome (table 2), dysmetria, 2“4 0 7 
dysdiadochokinesis,2 7 frontal headaches,2 and 
pes cavus1 2 6 have also been reported. Absent 
as well as increased deep tendon reflexes have 
been observed. The neurological symptoms are 
often slowly or non-progressive. Although in 
m ost cases the first neurological symptoms 
occurred in the third decade of life313 6-10 the 
onset of cerebellar ataxia started before 15 
years of age in at least seven patients .2 5-7 The 
late onset or recognition of the ataxic symp-
Table 1 Prominent clinical features and differential diagnosis o f the cases described
Features
Boucher-Neuhäuser
syndrome IO S C A
Holmes type 
ataxia
Oliver-McFarlane
syndrome Case 1 Case 2
Chorioretinal degeneration + — (+) + + +
Cerebellar ataxia -f + — + +
Hypogonadotrophic
hypogonadism + + + + +
Hypergonadotrophic
hypogonadism
« + M l
Mental retardation — — + + — —
Trichomegaly — — — + + +
Alopecia — — — + —
Prenatal onset growth retardation — — + mm* —
IOSCA = Infantile onset spinocerebellar ataxia. For references see text. 
Retinal degeneration is seen in some patients with Holmes type ataxia.15
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toms can make the diagnostic process very dif­
ficult and the dyad of hypogonadotrophic 
hypogonadism and retinal degeneration with­
out additional symptoms does not conform to 
any diagnosis. In fact, we found only one report 
describing such an association.20 These authors 
described three sisters with hypogonadotrophic 
hypogonadism and retinitis pigmentosa. In 
addition to these sisters a prepubertal younger 
brother with retinitis pigmentosa was m en­
tioned. Since the age of these patients did not 
exceed 22  years* it is not unlikely that the ataxic 
symptoms were recognised later in life, like the 
patients of the present study, but only a 
re-evaluation of these cases will prove this 
assumption to be correct.
In contrast to the ocular and ataxic symp­
toms, the endocrinological findings became 
evident at the time puberty was expected. Pri­
mary amenorrhoea, poor development of 
sexual organs, and sparse growth of secondary 
sexual hair prompted the diagnosis of hypogo­
nadism. On testing, LH  and FSH  were 
deficient in all reported cases1 10 (present 
study). The absence of a response to LH  
releasing horm one injections strongly suggests 
a disturbed pituitary function5*8 (present 
study). The pattern of T S H  and prolactin 
response to T R H  plus the G H  response to 
G RF and insulin induced hypoglycaemia in 
some patients provide evidence for an addi­
tional involvement of the hypothalamus.5 8 In 
all patients these functional defects will result 
in infertility. Azoospermia has been reported in 
two male subjects.6 However, fertility can be 
restored by means of horm one substitution. In 
fact, two female patients with Boucher- 
N euhäuser syndrome gave birth to a child after 
such treatm ent.8 9
The association of Boucher-Neuhäuser syn­
drome with hypocalciuric hypercalcaemia was 
reported once in a female patient.8 As a result, 
she suffered from hair loss and several 
compression fractures. T he cause of this 
hypocalciuric hypercalcaemia remained un­
known, but the hypothesis that this disorder is
part o f the inherited syndrome seems unlikely. 
The patient was "assumed to be under 
postmenopausal state for over 10 years”, and 
this lack of oestrogens seemed to play an 
im portant role in the pathogenesis.8 Further­
more, one sister of this patient with almost the 
same clinical history and symptoms had no 
hypercalcaemia.8 9
Besides the observation that the tissues 
involved are all of neuroectodermal origin, the 
exact link between the three disorders (chorio­
retinal degeneration, hypogonadotrophic hy­
pogonadism, and cerebellar ataxia) remains 
unknown. All the reported cases provide 
evidence that this triad represents a specific 
pleiotropic single gene disorder with an auto­
somal recessive pattern of inheritance. Males 
and females are equally affected and all cases 
are sibs in a single generation with unaffected 
parents. In addition, consanguinity was present 
in three of the reported families2 7 8 and the 
karyotypes of all tested subjects were 
norm al1 3“8 (present study). However, the na­
ture of the gene involved and the role it plays in 
the pathophysiology is still unknown. Recently, 
a single 5.5 kb mitochondrial DNA deletion 
was found in lymphocytes of a patient with 
ataxia, hypogonadism, choroidal dystrophy, 
and other symptoms.21 Mitochondrial metabo­
lism deficiency in a patient with Holmes type 
ataxia and hypogonadism has been reported 
before, 15 and also the occurrence of ataxia and 
retinal degeneration in patients with mitochon­
drial myopathy has been reported .22 Investiga­
tion of mitochondrial DNA of one of the 
patients reported in the present study, however, 
did not show any abnormalities.
U ntil specific tests are available, the diagno­
sis of Boucher-Neuhäuser syndrome must be 
made on the basis of clinical findings. The 
identification and description of additional 
cases is important to improve our understand­
ing of this rare syndrome and to distinguish 
between other disorders associating hypogo­
nadism or retinal degeneration with ataxia.
Table 2 Clinical manifestations of Boucher-Neuhäuser syndrome *
Present N o t present Unknown
Feature (n -1 9 ) N o % N o % No %
Complete triad 16 84 1 5 2 11
Ophthalmological findings
Loss of vision 14 74 1 5 4 21
Loss of colour discrimination 5 26 2 11 12 63
(Ring) scotoma 9 47 0 0 10 53
Retinal degeneration 16 84 0 0 3 16
Disturbed ERG 9 47 0 0 10 53
Neurological findings
Disturbed balance/gait 17 89 0 0 2 11
Disturbed speech 9 47 4 21 6 32
Nystagmus 12 63 2 11 5 26
Cerebellar atrophy (CT/MRI) 10 53 2 11 7 37
Endocrinological findings
Primary amenorrhoea (females) 9 90 1 10 0 0
Hypoplastic sexual organs 13 68 1 5 5 26
Sparse secondary sexual hair 12 63 2 11 5 26
Low LH/FSH 16 84 0 0 3 16
No response to LH-RH 8 42 0 0 11 58
Normal intelligencef 9 47 3 16 7 37
Normal karyotype 13 68 0 0 6 32
*Compiled from references 1 to 105 including the cases presented in this study.
+On all three occasions when intelligence was not considered, normal, it was either attributed to the loss of vision or regarded as low 
normal.
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